Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell trans...

por Zhou, Ling, Lu, Dao-pei
Publicado en Virol J (2019)

Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical h...

por Zhou, Ling, Gao, Zhi-yong, Lu, Dao-pei
Publicado en Ann Hematol (2020)

Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells

por LIU, JIN HONG, BIAN, YONG MEI, XIE, YI, LU, DAO PEI
Publicado en Mol Med Rep (2015)

Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient

por Zhang, Jian-Ping, Zhang, Rui, Tsao, Shih-Ting, Liu, Yu-Chen, Chen, Xiaochuan, Lu, Dao-Pei, Castillo, Paul, Chang, Lung-Ji
Publicado en Blood Adv (2018)

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemother...

por Zhao, Yan-Li, Liu, De-Yan, Sun, Rui-Juan, Zhang, Jian-Ping, Zhou, Jia-Rui, Wei, Zhi-Jie, Xiong, Min, Cao, Xing-Yu, Lu, Yue, Yang, Jun-fang, Zhang, Xian, Lu, Dao-Pei, Lu, Peihua
Publicado en Front Immunol (2021)

The outcomes of family haploidentical hematopoietic stem cell transplantation in hematological malignancies are not associated with patient age

por Dong, Lujia, Wu, Tong, Gao, Zhi-Yong, Zhang, Mei-Jie, Kan, Fangyu, Spellman, Stephen R., Tan, Xi-You, Zhao, Yan-Li, Wang, Jing-Bo, Lu, Dao-Pei, Miklos, David, Petersdorf, Effie, Fernandez-Vina, Marcelo, Lee, Stephanie J.
Publicado 2010